A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus

10.1093/neuonc/nou223

Choy, 2011, The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments, Neurosurg Focus, 30, E6, 10.3171/2011.2.FOCUS1116

10.1016/S1474-4422(06)70625-1

10.1007/s11060-010-0342-2

10.1097/WCO.0000000000000035

10.1007/s11060-010-0349-8

10.3171/jns.2000.92.2.0306

10.1016/j.surneu.2007.06.031

10.3171/jns.1992.77.4.0590

10.1038/labinvest.3700307

10.1227/00006123-199009000-00008

10.1158/1078-0432.CCR-12-0299

10.1038/ng.2526

10.1126/science.1233009

10.1038/nbt.2287

Ning, 2014, Oncolytic herpes simplex virus–based strategies: toward a breakthrough in glioblastoma therapy, Front Microbiol, 5, 303, 10.3389/fmicb.2014.00303

10.1073/pnas.101136398

10.1093/neuonc/not317

10.1158/1078-0432.CCR-05-1090

10.1038/sj.gt.3302445

10.1038/sj.cgt.7701037

10.1158/0008-5472.CAN-08-3886

10.1007/978-1-4614-3146-6_14

Yazaki, 1995, Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1, Cancer Res, 55, 4752

10.1093/jnen/61.12.1048

10.1242/jcs.159400

10.1016/j.nbd.2007.09.002

10.1093/neuonc/nor195

10.1186/gb-2011-12-1-r1

10.1038/nm0995-938

10.1158/1078-0432.CCR-10-3142

10.1073/pnas.1307935110

10.5966/sctm.2011-0035

Singh, 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res, 63, 5821

10.1007/s00401-013-1195-5

10.1111/bpa.12110

10.1038/cgt.2012.49

10.1016/j.ccr.2006.03.030

10.1186/s12967-015-0596-8

10.1007/s11060-010-0469-1

10.1016/j.yexmp.2010.12.003

10.1016/j.acthis.2010.09.005

10.1002/gcc.20141

10.1128/MCB.01581-08

10.1158/1541-7786.MCR-11-0425-T

10.1016/S0006-291X(03)00124-4

10.1126/scitranslmed.3008599

10.1089/hum.2006.17.20

10.1227/01.NEU.0000146207.55774.69

10.1158/1078-0432.CCR-06-0263